TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
MDXG

MiMedx Group Inc

Healthcare · Biotechnology

4.70$ -1.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow MDXG
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
14.2% 10.0% 9.7% 19.6% 10.0% 10.0% -15.9% -0.8% -6.7% 8.3% 19.0% 17.7%
1.8% 1.5% 2.2% 1.8% 1.9% 1.9% 3.1% 2.1% 1.5% 1.1% 1.7% 3.6%
9.7% 9.0% 7.2% 6.6% – 4.1% 4.9% 5.8% 4.7% 5.3% 4.9% 3.9%
14.7% 7.1% 4.7% -2.2% 11.8% 3.3% 8.9% 6.7% 6.3% – – –
-2.5% -12.4% 2.6% -0.2% -0.1% 5.2% -8.1% -8.0% -3.4% -5.7% -1.6% -5.5%
2.2% 3.1% 2.5% 1.6% 2.6% 2.6% 0.9% 1.3% 1.0% 0.6% 0.5% 0.2%
-10.3% -0.4% -4.8% -1.7% -2.6% -2.6% -1.8% -1.4% -1.0% -0.7% -2.7% -1.6%
0.0% 0.0% 0.0% – – – 40.3% 0.6% 0.2% 0.3% – –
-4.7% -21.5% -4.7% -22.5% -1.1% -3.5% -0.6% -2.0% -0.4% -3.0% -0.8% -0.7%
-0.1% -0.3% 0.0% 0.0% 0.0% 17.9% -11.7% 0.0% 0.0% 0.0% -9.1% -0.2%
-1.8% -19.3% -3.3% -18.8% -2.5% -2.5% 25.3% -1.4% -0.2% -2.7% -9.8% -1.3%
2.1% -9.7% 1.6% -0.9% 4.9% 4.9% 9.6% -3.6% -7.9% 5.0% 6.4% 14.7%
12.0% 6.9% 7.2% 18.0% 7.2% 7.3% -16.8% -2.1% -7.7% 7.7% 18.5% 17.4%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?